Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 71 Results
Age
Type
Conditions or Disease:

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

Tahseen Mozaffar

  • OPEN TO ACCRUAL

PhII NanO2TM Combo w/Rad&Temozolomide Pa w/NewlyDia GlioblsdtomaMultiforme: RESTORE

Xiao-Tang Kong

  • OPEN TO ACCRUAL

Double-Blind use of Staccato Alprazolam for participants with prolonged seizures

Lilit Mnatsakanyan

  • OPEN TO ACCRUAL

PhI KT-333 in Adult Patients w/ R/R Lymphomas, Large Granular Lymphocytic Leukemia, & Solid Tumors

Lauren C Pinter-Brown

  • OPEN TO ACCRUAL

Advarra Reliance #26: Neuromuscular Observational Research (MOVR) Data Hub Protocol Pro00034893

Tahseen Mozaffar

  • OPEN TO ACCRUAL

PhI DoseEscalationExpandedCohort P-MUC1C-ALLO1 AdultSubjects AdvancedMeta SolidTumors

Rita Mehta

  • OPEN TO ACCRUAL

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Mona Sazgar

  • OPEN TO ACCRUAL

A Study to Evaluate PF-06823859 in People With Active Idiopathic Inflammatory Myopathies

Namita Goyal

  • OPEN TO ACCRUAL

PhII Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma

Daniela Bota

  • OPEN TO ACCRUAL

Venglustat on neuropathic and abdominal pain in male and female adults with Fabry disease

Changrui Xiao

  • OPEN TO ACCRUAL

PhI BI 1810631 as Monotherapy in Pts w/ Adv or Metastatic Solid Tumors w/ HER2 Aberrations

Misako Nagasaka

  • OPEN TO ACCRUAL

Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Manisha Korb

  • OPEN TO ACCRUAL

A Phase I/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

Misako Nagasaka

  • OPEN TO ACCRUAL

PhI/IINivolumab+-Ipilimumabw/MultiFractionStereotacticRadiosurRecurHighGradeRadiationRelapsedMeningi

Aaron Simon

  • OPEN TO ACCRUAL